That's the good news. The bad news is that the bloom may be coming off the GLP-1 rose, which is presumably the reason why not only EliLilly but NovoNordisk and Viking Therapeutics stock are ...
Both companies have a dominant position in their industry and a solid financial position, but EliLilly seems too pricey right now. In contrast, NovoNordisk seems rather cheap given. The ...
Weight loss goals may be at the forefront of many New Year's resolutions, which could push the exuberance for EliLilly LLY and NovoNordisk NVO stock. As the major players in the hyper-scale ...